眼科中的肉毒杆菌毒素。
Botulinum toxin in ophthalmology.
作者信息
Dunlop D, Pittar G, Dunlop C
出版信息
Aust N Z J Ophthalmol. 1988 Feb;16(1):15-20. doi: 10.1111/j.1442-9071.1988.tb01194.x.
Alan B. Scott selected, researched and developed Type A Botulinum toxin for clinical use in ophthalmology. This unique drug has proved invaluable for treatment of a number of conditions which are difficult to treat in ophthalmology and in a variety of other disciplines. The indications, methods and problems of its use are described and the results of treatment of 133 patients are discussed. Up to December 1986 over 13,000 patients have been treated in a multicentre international trial without significant complications.
艾伦·B·斯科特筛选、研究并开发了A型肉毒杆菌毒素用于眼科临床。这种独特的药物已被证明在治疗眼科及其他多个学科中一些难以治疗的病症方面具有极高价值。文中描述了其使用的适应症、方法及问题，并讨论了133例患者的治疗结果。截至1986年12月，超过13000名患者在一项多中心国际试验中接受了治疗，未出现重大并发症。
Zotero 插件